Abstract:PurposeTo assess the efficacy of a newly designed retrievable drug eluting stent for the treatment of benign cardia stricture in a canine model versus group that received bare stent insertion.Materials and MethodsForty-eight achalasia-like dog models were randomly divided into a control group (CG; no stent insertion), a bare stent group (BSG, n=16) and a drug eluting stent group (BESG, n=16). All stents were retrieved four days after insertion. Lower-esophageal-sphincter pressures (LESP) and the 5-min barium height (5-mBH) were assessed before and immediately after the procedure, and at 1-week, 1-, 3- and 6-month follow-up. Four dogs in each group were sacrificed for histological examination.ResultsCardia stent insertion was tolerated by all subjects, with similar stent migration rate of DES or BS (5.6% vs. 11.1%; P=0.3636). At the 6-month follow-up, the values of LESP and 5-mBH in the BESG is more stable compared to those in the BSG (p<0.05). Immunohistochemistry for mouse anti-proliferating cell nuclear antigen (PCNA) and α-smooth muscle actin revealed alleviate inflammatory reaction peak in the BESG than in the BSG (p<0.05). Collagen proliferation was most severe after 6 months in the BSG (p<0.05).ConclusionThe novel drug eluting cardia stent was more effective than bare stent for the treatment of this benign cardia stricture canine model. Further studies are required to assess if the recurrence rate is lower due to less inflammation and scarring in a long-term. PurposeTo assess the efficacy of a newly designed retrievable drug eluting stent for the treatment of benign cardia stricture in a canine model versus group that received bare stent insertion. To assess the efficacy of a newly designed retrievable drug eluting stent for the treatment of benign cardia stricture in a canine model versus group that received bare stent insertion. Materials and MethodsForty-eight achalasia-like dog models were randomly divided into a control group (CG; no stent insertion), a bare stent group (BSG, n=16) and a drug eluting stent group (BESG, n=16). All stents were retrieved four days after insertion. Lower-esophageal-sphincter pressures (LESP) and the 5-min barium height (5-mBH) were assessed before and immediately after the procedure, and at 1-week, 1-, 3- and 6-month follow-up. Four dogs in each group were sacrificed for histological examination. Forty-eight achalasia-like dog models were randomly divided into a control group (CG; no stent insertion), a bare stent group (BSG, n=16) and a drug eluting stent group (BESG, n=16). All stents were retrieved four days after insertion. Lower-esophageal-sphincter pressures (LESP) and the 5-min barium height (5-mBH) were assessed before and immediately after the procedure, and at 1-week, 1-, 3- and 6-month follow-up. Four dogs in each group were sacrificed for histological examination. ResultsCardia stent insertion was tolerated by all subjects, with similar stent migration rate of DES or BS (5.6% vs. 11.1%; P=0.3636). At the 6-month follow-up, the values of LESP and 5-mBH in the BESG is more stable compared to those in the BSG (p<0.05). Immunohistochemistry for mouse anti-proliferating cell nuclear antigen (PCNA) and α-smooth muscle actin revealed alleviate inflammatory reaction peak in the BESG than in the BSG (p<0.05). Collagen proliferation was most severe after 6 months in the BSG (p<0.05). Cardia stent insertion was tolerated by all subjects, with similar stent migration rate of DES or BS (5.6% vs. 11.1%; P=0.3636). At the 6-month follow-up, the values of LESP and 5-mBH in the BESG is more stable compared to those in the BSG (p<0.05). Immunohistochemistry for mouse anti-proliferating cell nuclear antigen (PCNA) and α-smooth muscle actin revealed alleviate inflammatory reaction peak in the BESG than in the BSG (p<0.05). Collagen proliferation was most severe after 6 months in the BSG (p<0.05). ConclusionThe novel drug eluting cardia stent was more effective than bare stent for the treatment of this benign cardia stricture canine model. Further studies are required to assess if the recurrence rate is lower due to less inflammation and scarring in a long-term. The novel drug eluting cardia stent was more effective than bare stent for the treatment of this benign cardia stricture canine model. Further studies are required to assess if the recurrence rate is lower due to less inflammation and scarring in a long-term.

Temporary Self-Expanding Cardia Stents for the Treatment of Achalasia:An Experimental Study in Dogs

A Newly-Designed Temporary Cardia Stent for the Treatment of Achalasia:An Experimental Study in Canine Models

Application of the Newly Developed Stents in the Treatment of Benign Cardia Stricture: an Experimental Comparative Study

Abstract No. 106: The application of the newly developed drug-eluting stents for the treatment of benign cardia stricture dog models

Abstract No. 105: Biodegradable self-expanding stents for the treatment of benign cardia stricture in a dog model

Temporary Placement of a Paclitaxel or Rapamycin-Eluting Stent is Effective to Reduce Stenting Induced Inflammatory Reaction and Scaring in Benign Cardia Stricture Models.

Sutureless Choledochoduodenostomy with an Intraluminal Degradable Stent in Dog Model.

Long-term follow-up study of dilation with temporary cardia stent in different diameters for achalasia

Temporary Self-Expanding Metallic Stents for Achalasia: A Prospective Study with a Long-Term Follow-Up

Long-term Safety and Outcome of a Temporary Self-Expanding Metallic Stent for Achalasia: a Prospective Study with a 13-Year Single-Center Experience

Comparison Of Temporary Stent Insertion With Pneumatic Dilation Of The Same Diameter In The Treatment Of Achalasia Patients: A Retrospective Study

A Comparative Study Between Temporary Esophageal Stenting and Balloon Dilatation for Achalasia

Interventional therapy of achalasia with temporary metal internal stent dilatation and its intermediate and long term follow-up

Selection and Evaluation of Three Interventional Procedures for Achalasia Based on Long-Term Follow-Up

Biodegradable Rapamycin-Eluting Nano-Fiber Membrane-Covered Metal Stent Placement to Reduce Fibroblast Proliferation in Experimental Stricture in a Canine Model

Evaluation of biodegradable paclitaxel-eluting nanofibre-covered metal stents for the treatment of benign cardia stricture in an experimental model.

13-Year Follow-Up of A Prospective Comparison of the Long-Term Clinical Efficacy of Temporary Self-Expanding Metallic Stents and Pneumatic Dilatation for the Treatment of Achalasia in 120 Patients

Temporary Self-Expanding Metallic Stents and Pneumatic Dilation for the Treatment of Achalasia: a Prospective Study with a Long-Term Follow-Up

Comparison of Tissue Reaction with Three Different Endografts Used for Exclusion of Carotid Artery Aneurysm in a Dog Model.

Autonomic and Neuroendocrine Responses to Rectosigmoid Stimulation

Establishment and Observation of Animal Model with Benign Proliferative Stenosis after Esophageal Stent Implantation